Immunovant
IMVT
IMVT
192 hedge funds and large institutions have $1.61B invested in Immunovant in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 45 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.65% less ownership
Funds ownership: 56.06% → 55.41% (-0.65%)
21% less capital invested
Capital invested by funds: $2.04B → $1.61B (-$429M)
Holders
192
Holding in Top 10
6
Calls
$34.5M
Puts
$29.5M
Top Buyers
| 1 | +$70.8M | |
| 2 | +$64.1M | |
| 3 | +$59.8M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$14.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.7M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$24.4M | |
| 3 | -$20.4M | |
| 4 |
RI
RTW Investments
New York
|
-$13.1M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$11.6M |